Pain with sex and a decreased desire for sex are common in women after cancer treatment. This presentation explains how the sexual response cycle works, medical interventions you can use to address genital health problems after transplant or CAR T-cell therapy, and other strategies you can use to regain intimacy with your partne

Graft-versus-host disease (GVHD) is a common complication after a bone marrow/stem cell transplant using donor cells (allogeneic transplant). This presentation will discuss current techniques to prevent GVHD, new drugs to treat acute and chronic GVHD and clinical trials testing new GVHD therapies.

Graft-versus-host disease (GVHD) often affects the skin, nails, hair, mouth and/or genitals. This presentation will discuss potential treatments for various forms of acute and chronic skin GVHD, dry skin care, sun protection and how to monitor your skin for skin wounds and skin cancer.

Cognitive challenges, especially memory problems, can develop after a bone marrow/stem cell transplant or CAR T-cell therapy. This presentation describes strategies that you can use to address memory problems and improve your quality of life.

The importance of sleep is evidenced by the fact that humans spend nearly a third of their lives sleeping, yet sleep disturbances are very common. This presentation reviews common sleep difficulties and strategies to improve sleep.

Cancer-related fatigue can be managed, and endurance can be rebuilt. Learn about strategies to conserve energy; adaptive equipment that can help with energy conservation; and improving stamina and strength through exercises that patients can perform at home. Also learn to identify when it is appropriate to seek help from a physical or occupational therapist.

New cancers can develop after a stem cell transplant using your own (autologous) or donor (allogeneic) stem cells. This presentation describes what types of cancers may develop, risk factors and what you can do to reduce your risk of developing a secondary cancer,

People who undergo a stem cell transplant or CAR T-cell therapy have an increased risk of infection after treatment. This presentation discusses who’s at risk, when infections typically arise, steps taken by transplant teams to avoid and treat infections and steps patients can take to reduce their risk of developing a serious infection.

Caregivers are critical to the United States (US) Health Care system as more procedures are moved outpatient and home care is required. Yet they must deal with the emotional toll of the responsibilities, the financial impact of being a caregiver and the accompanying negative emotions. Often times, caregivers are required to perform tasks previously performed by medical professionals yet caregivers don’t necessarily have the training. Just like the cancer patients, caregivers experience a whole range of negative emotions which need to be acknowledged and addressed.

The overall health of the gut microbiome and its organisms can influence the prevalence and severity of graft-versus-host disease. This presentation reviews the causes and mechanisms of how organisms in the gut can affect GVHD and reviews potential strategies to minimize this problem.